These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diabetes drug safety update: Avandia and your heart. Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316 [No Abstract] [Full Text] [Related]
3. Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. Woodcock J; Sharfstein JM; Hamburg M N Engl J Med; 2010 Oct; 363(16):1489-91. PubMed ID: 20942663 [No Abstract] [Full Text] [Related]
4. Revisiting the rosiglitazone story--lessons learned. Rosen CJ N Engl J Med; 2010 Aug; 363(9):803-6. PubMed ID: 20660395 [No Abstract] [Full Text] [Related]
5. Warner Lambert/Sankyo diabetes drug nears market. Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120 [No Abstract] [Full Text] [Related]
7. Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones? Freemantle N BMJ; 2010 Sep; 341():c4812. PubMed ID: 20819888 [No Abstract] [Full Text] [Related]
9. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes. Misbin RI Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753 [No Abstract] [Full Text] [Related]
10. Major US consumer group asks FDA to ban drug for diabetes. Tanne JH BMJ; 2008 Nov; 337():a2401. PubMed ID: 18987042 [No Abstract] [Full Text] [Related]
11. [Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]. Schernthaner G; Forst T; Gulba D; Haberbosch W; Hanefeld M; Linss G; März W; Mehnert H; Rosak C; Schnell O; Seufert J; Tschöpe D; Erdmann E Dtsch Med Wochenschr; 2009 Apr; 134(18):949-54. PubMed ID: 19384816 [TBL] [Abstract][Full Text] [Related]
12. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes. Lehmann DF; Lohray BB J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500 [No Abstract] [Full Text] [Related]
18. The value equation for rosiglitazone and pioglitazone in older persons. Zarowitz BJ Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172 [No Abstract] [Full Text] [Related]
19. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications. Stockl KM; Le L; Zhang S; Harada AS Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity. Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]